Merrimack Pharmaceuticals Plans Liquidating Dividend

Merrimack Pharmaceuticals Inc. (MACK) just unveiled an announcement.

Merrimack Pharmaceuticals announced its intention to pay a liquidating cash dividend of $15.10 per share, subject to stockholder approval at an upcoming special meeting. Although the exact amount of future distributions is uncertain and could change, initial estimates indicate $15.10 per share with the possibility of additional distributions if reserved funds are no longer needed or if certain milestones are met under existing agreements. The press release detailing this announcement has been made available both on the SEC’s website and on Merrimack’s company website.

See more insights into MACK stock on TipRanks’ Stock Analysis page.